Cetylpyridinium chloride inhibits hepatocellular carcinoma growth and metastasis through regulating epithelial-mesenchymal transition and apoptosis
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0310391 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Kundi Cai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi Normal University, Jiangxi, China. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Carcinoma, Hepatocellular, Liver Neoplasms, Apoptosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is characterized by a lack of obvious clinical features in the early stages and is likely to progress to advanced HCC. Advanced HCC is a highly malignant tumor. However, there are few treatment options for advanced HCC. Therefore, screening for new drugs that target HCC will provide a new approach to the treatment of HCC. The CCK8 assay was performed to screen compounds inhibiting HCC cell proliferation and to evaluate the IC 50 (half-maximal inhibitory concentration) of compounds on cell lines. Colony formation assay was used to determine HCC cell proliferation. The effect of compounds on HCC cell migration and invasion were analyzed using wound healing and transwell assays, respectively. Tumor growth and metastasis were assessed in vivo in a xenograft mouse model. Flow cytometry was carried out to measure apoptotic cells. Reverse transcription and quantitative real-time polymerase chain reaction (RT‒qPCR) and Western blot were performed to examine the expression of epithelial-mesenchymal transition (EMT)- and apoptosis-related genes. Through large-scale screening, we have discovered the anti-tumor activity of cetylpyridinium chloride (CPC) against HCC cells. CPC inhibited the proliferation, invasion and metastasis of HCC cells. Cancer cells are more sensitive to CPC than normal cells. CPC suppressed HCC tumor growth and metastasis in vivo . Mechanistically, CPC promoted apoptosis of HCC cells by affecting the expression of apoptosis-related genes, and inhibited HCC invasion and metastasis by suppressing EMT and expression of EMT markers. Our investigation showed that CPC significantly inhibited HCC cell proliferation, invasion and metastasis in vivo and in vitro , by inducing the expression of apoptosis-related genes and inhibiting expression of EMT markers, suggesting that CPC is a potential agent for HCC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Jiangxi Normal University, Jiangxi, China.
- Laboratory of advanced biotechnology, Department of Cell Engineering, Beijing Institute of Biotechnology, Beijing, China.
ORCID-Profile: Lihua Ding
Förderung
- National Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Cai, K., Fang, Y., Zhang, Y., Liu, J., Ye, Q., Ding, L., & Cai, X. (2024). Cetylpyridinium chloride inhibits hepatocellular carcinoma growth and metastasis through regulating epithelial-mesenchymal transition and apoptosis. PLOS ONE. https://doi.org/10.1371/journal.pone.0310391
Vancouver
Cai K, Fang Y, Zhang Y, Liu J, Ye Q, Ding L, et al. Cetylpyridinium chloride inhibits hepatocellular carcinoma growth and metastasis through regulating epithelial-mesenchymal transition and apoptosis. PLOS ONE. 2024. doi:10.1371/journal.pone.0310391
BibTeX
@article{Cai2024,
author = {Cai, Kundi and Fang, Yihui and Zhang, Yanan and Liu, Jie and Ye, Qinong and Ding, Lihua and Cai, Xianfeng},
title = {Cetylpyridinium chloride inhibits hepatocellular carcinoma growth and metastasis through regulating epithelial-mesenchymal transition and apoptosis},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0310391}
}
EUVIMED